课题基金 / 基金详情

Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic

Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic
转化乳腺癌研究中心 (TransBCR):将实验室发现交付给临床
批准号:
nhmrc : GNT1153049
负责人:
A/Pr Elgene Lim
金额:
$249.64万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Centres of Research Excellence
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

A/Pr Elgene Lim的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
TransBCR is a cooperative multidisciplinary translational research program, leveraging off newly established Comprehensive Cancer Centres and Clinical Trial Groups including Cancer Trials Australia and Breast Cancer Trials. TransBCR’s mission is to bridge the translational gap (the ‘Valley of Death’) between world-class research discoveries and their transfer to early phase trials for patients with breast cancer, while advancing the training of the next generation of breast cancer researchers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pushing AR toward better outcomes in breast and prostate cancers
  • 批准号:
    nhmrc : 1145777
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.53万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Development of a novel and highly selective CDK4/6 inhibitor for treating cancer
  • 批准号:
    nhmrc : GNT1135682
  • 项目类别:
    Development Grants
  • 资助金额:
    $117.12万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Development of a novel and highly selective CDK4/6 inhibitor for treating cancer
  • 批准号:
    nhmrc : 1135682
  • 项目类别:
    Development Grants
  • 资助金额:
    $79.19万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
Targeting the Oncoprotein MDMX as a Novel Treatment for Triple Negative Breast Cancer
  • 批准号:
    nhmrc : 1123057
  • 项目类别:
    Project Grants
  • 资助金额:
    $38.34万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Elgene Lim
  • 依托单位:
海外基金